Federal government employment and security clearances have distinct cannabis drug testing requirements that state legalisation does not override. Evolving recency policies at some
Executive Order 12564 (1986) established the Drug-Free Federal Workplace programme, requiring drug testing for all federal employees in designated Testing Designated Positions (TDPs). All federal agencies must test for the SAMHSA-5 panel: THC, cocaine, opioids, amphetamines, and PCP. Tests use SAMHSA-certified laboratories with the 50 ng/mL urine cutoff for screening and 15 ng/mL GC/MS for confirmation. Understanding how the standard urine drug test process works explains why federal labs use these specific thresholds.
Cannabis use affects security clearance adjudication under the 13 Adjudicative Guidelines. Intelligence community agencies (CIA, NSA, DIA) typically require 12 months of cannabis abstinence before hiring, with some extending this to 24 months for sensitive positions. The State Department requires up to 12 months abstinence for diplomatic security roles. In 2023, the CIA updated its policy to allow applicants who used cannabis in the past but require cessation upon employment. The Department of Justice and FBI generally require 1–3 years of abstinence depending on the role. Private sector employment testing differs significantly from federal clearance requirements.
The DEA, FBI, Secret Service, Border Patrol, and most law enforcement agencies maintain the strictest cannabis policies, often requiring 3+ years of abstinence. Military branches and VA-adjacent healthcare roles follow DoD zero-tolerance standards — see the military drug testing guide for specifics. The FAA requires aviation workers to comply with DOT 49 CFR Part 40 drug testing requirements. NASA, EPA, and non-security scientific agencies have somewhat more flexible past-use policies while still requiring cessation upon employment. CBD vs THC distinctions are generally not recognised for federal security clearance purposes.
A notable trend since 2021 has been agency-level updates to past-use recency standards. The CIA, NSA, and Secret Service have each issued guidance acknowledging widespread legal cannabis use in recruiting markets. The general direction: past experimentation is less disqualifying than it once was; recent or ongoing use remains disqualifying. For roles requiring TOP SECRET/SCI clearance, the standard remains essentially absolute: no use since hiring, minimal use in the period before application. Delta-8 THC and other hemp-derived cannabinoids are treated identically to delta-9 THC in federal drug testing contexts. Also consider CBD risks in federal testing contexts.